Joy Wu

Gerald M. Reaven, MD Professor of Endocrinology

Bio

Dr Joy Wu is Chief of the Division of Endocrinology and Vice Chair of Basic Science in the Department of Medicine at Stanford. She is a board-certified endocrinologist who specializes in treating osteoporosis and other bone and mineral diseases. She has a special interest in optimizing skeletal health for those at risk of bone loss from glucocorticoid treatment, cancer therapies, or organ transplant. She has served on expert panels and guideline committees for the American Society for Transplantation and Cellular Therapy, the American Society of Clinical Oncology, and the Endocrine Society.

Dr. Wu also directs a basic and translational research program that focuses on skeletal development and the bone marrow hematopoietic niche. Her laboratory is currently studying stem cell therapies for bone formation, and the prevention of cancer metastases to bone (joywulab.stanford.edu). She has been honored with awards from the NIH Director’s New Innovator Award, the Endocrine Society, the American Society for Bone and Mineral Research, and the Mary Kay Foundation, and she is a standing member of the NIH Skeletal Biology Development and Disease study section panel. She has served on the Board of Directors for the Endocrine Society and is currently a member of the governing Council of the American Society for Bone and Mineral Research.

Clinical Focus

Osteoporosis
Metabolic Bone Disease
Endocrinology
Diabetes and Metabolism

Academic Appointments

Professor, Medicine - Endocrinology, Gerontology, & Metabolism
Member, Bio-X
Member, Wu Tsai Human Performance Alliance
Member, Maternal & Child Health Research Institute (MCHRI)
Member, Stanford Cancer Institute

Administrative Appointments

Chief, Division of Endocrinology, Gerontology and Metabolism (2022 - Present)
Steering Committee Member, Team Science Initiative, Department of Medicine (2022 - Present)
Vice Chair, Basic and Translational Science, Department of Medicine (2020 - Present)
Associate Member, Stanford Diabetes Research Center (2018 - Present)
Co-Director, Translational Investigator Program, Department of Medicine (2015 - 2022)

Honors & Awards

Faculty Women's Forum Allyship Award, Stanford University (2021)
Fellow, American Society for Bone and Mineral Research (2021)
Alford Distinguished Lecture, Baylor College of Medicine (2019)
Cancer Grant Recipient, The Mary Kay Foundation (2013)
NIH Director's New Innovator Award, NIH (2011)
Claflin Distinguished Scholar Award, Massachusetts General Hospital (2009)
Clinical Scientist Program Instructor Development Award, Harvard Stem Cell Institute (2009)
John Haddad Young Investigator Award, Advances in Mineral Metabolism (2008)
Merck Senior Fellow Award, The Endocrine Society (2007)
Endocrine Scholars Award, The Endocrine Society (2006)
Young Investigator Award, American Society for Bone and Mineral Research Annual Meeting (2006)
Alpha Omega Alpha, Duke University School of Medicine (1997)
Marsden Memorial Award in Chemistry, Stanford University (1993)
Phi Beta Kappa, Stanford University (1993)

Boards, Advisory Committees, Professional Organizations

Chair, 2026 Bones and Teeth Gordon Research Conference (2024 - Present)
Councilor, American Society for Bone and Mineral Research (2022 - Present)
Member, Scientific Advisory Board, Crinetics Pharmaceuticals (2022 - Present)
Vice Chair, 2024 Bones and Teeth Gordon Research Conference (2022 - 2024)
Member, Skeletal Biology Development and Disease Study Section, NIH (2020 - 2024)
Member, Board of Directors, The Endocrine Society (2019 - 2022)
Leadership Task Force, The Endocrine Society (2015 - 2015)
Board of Directors, Advances in Mineral Metabolism (2013 - 2016)
Membership Enhancement Committee, The American Society for Bone and Mineral Research (2013 - 2016)
Co-Chair, Trainee & Career Development Core Committee, The Endocrine Society (2007 - 2010)
Ex Officio, Council, The Endocrine Society (2006 - 2010)
Member, The American Society for Bone and Mineral Research (2005 - Present)
Member, The Endocrine Society (2003 - Present)

Professional Education

Board Certification: American Board of Internal Medicine, Endocrinology, Diabetes and Metabolism (2006)
Fellowship: Massachusetts General Hospital (2006) MA
Residency: Brigham and Women's Hospital Harvard Medical School (2003) MA
Medical Education: Duke University School of Medicine (2001) NC
MD/PhD, Duke University (2001)

Contact

Academic jywu1@stanford.edu Tel: (650) 736-9654

Clinical (Primary)

This is the primary clinic for this clinical provider. For additional clinical locations and information, please visit the link(s) listed below in the 'Additional Clinical Info' section.

Endocrine Clinic within Ambulatory Care Clinic 300 Pasteur Dr Rm A13 Stanford CA 94305 Tel: (650) 721-1300 Fax: (650) 498-5823

Additional Clinical Info

Stanford Health Care

Current Research and Scholarly Interests

Osteoporosis, a disease of fragile bones resulting in fractures, will strike 50% of women and 25% of men. As a physician scientist, my laboratory is studying stem cells in the skeleton and bone marrow to develop novel regenerative approaches to increase bone quality and strength. We are also interested in how the skeleton supports hematopoiesis, and how diseases and medications that impact bone may affect blood cell production and cancer metastasis. For more detailed descriptions of ongoing research projects in the lab, visit our website at joywulab.stanford.edu.

Clinical Trials

Pilot Trial of Zoledronic Acid to Prevent Bone Loss in Hematopoietic Cell Transplant Recipients Not Recruiting
More
Patients who undergo bone marrow transplant for different types of cancer are exposed to many treatments such as steroids and whole body radiation. These treatments make the transplant possible but also make their bones weaker and more prone to fractures which can be a source of significant disability and decreased quality of life for cancer survivors. Our trial will investigate whether giving one dose of Zoledronic acid (a commonly used drug given to preserve bone mass in osteoporosis) before bone marrow transplant can protect from the bone loss caused by the transplant procedures. The investigators are also interested in studying the complex interactions of bone, muscle and fat which are greatly affected after bone marrow transplant.

Stanford is currently not accepting patients for this trial. For more information, please contact Rodrigo Valderrabano, .

Lead Sponsor
- Stanford University
Stanford Investigators
- Joy Wu
View full details

2024-25 Courses

Independent Studies
- Directed Reading in Immunology
  IMMUNOL 299 (Aut, Win, Spr, Sum)
- Directed Reading in Medicine
  MED 299 (Aut, Win, Spr, Sum)
- Early Clinical Experience in Immunology
  IMMUNOL 280 (Aut, Win, Spr, Sum)
- Early Clinical Experience in Medicine
  MED 280 (Aut, Win, Spr, Sum)
- Graduate Research
  IMMUNOL 399 (Aut, Win, Spr, Sum)
- Graduate Research
  MED 399 (Aut, Win, Spr, Sum)
- Medical Scholars Research
  MED 370 (Aut, Win, Spr, Sum)
- Teaching in Immunology
  IMMUNOL 290 (Aut, Win, Spr, Sum)
- Undergraduate Research
  IMMUNOL 199 (Aut, Win, Spr, Sum)
- Undergraduate Research
  MED 199 (Aut, Win, Spr, Sum)

Stanford Advisees

Doctoral Dissertation Reader (AC)
Michelle Tai
Postdoctoral Faculty Sponsor
Xiyu Ge

Graduate and Fellowship Programs

Immunology (Phd Program)

All Publications

Profiles With Related Publications

close
Helen M. Blau

Donald E. and Delia B. Baxter Foundation Professor, Director, Baxter Laboratory for Stem Cell Biology and Professor, by courtesy, of Psychiatry and Behavioral Sciences
Research Interests
Prof. Helen Blau's research area is regenerative medicine with a focus on stem cells. Her research on nuclear reprogramming and demonstrating the plasticity of cell fate using cell fusion is well known and her laboratory has also pioneered the design of biomaterials to mimic the in vivo microenvironment and direct stem cell fate. Current findings are leading to more efficient iPS generation, cell based therapies by dedifferentiation a la newts, and discovery of novel molecules and therapies.

303 Total Publications
close
Sarah Bowling

Assistant Professor of Developmental Biology
Research Interests
The Bowling lab focuses on understanding lineage formation and tissue growth in mammalian development during normal and perturbed embryogenesis. We use a combination of next-generation tools and classical embryological approaches to uncover mechanisms of plasticity and resilience during mammalian embryo development, with the aim of using this knowledge to extend our understanding of regeneration and developmental diseases.

10 Total Publications
close
Anne Brunet

Michele and Timothy Barakett Endowed Professor
Research Interests
Our lab studies the molecular basis of longevity. We are interested in the mechanism of action of known longevity genes, including FOXO and SIRT, in the mammalian nervous system. We are particularly interested in the role of these longevity genes in neural stem cells. We are also discovering novel genes and processes involved in aging using two short-lived model systems, the invertebrate C. elegans and an extremely short-lived vertebrate, the African killifish N. furzeri.

161 Total Publications
close
Joonseok Cho

Basic Life Research Scientist, Medicine - Med/Endocrinology

14 Total Publications
close
Gerald Crabtree

David Korn, MD, Professor of Pathology and Professor of Developmental Biology
Research Interests
Chromatin regulation and its roles in human cancer and the development of the nervous system. Engineering new methods for studying and controlling chromatin and epigenetic regulation in living cells.

265 Total Publications
close
Margaret T. Fuller

Reed-Hodgson Professor of Human Biology, Katharine Dexter McCormick and Stanley McCormick Memorial Professor and Professor of Genetics and of Obstetrics/Gynecology (Reproductive and Stem Cell Biology)
Research Interests
Regulation of self-renewal, proliferation and differentiation in adult stem cell lineages. Developmental tumor suppressor mechanisms and regulation of the switch from proliferation to differentiation. Cell type specific transcription machinery and regulation of cell differentiation. Developmental regulation of cell cycle progression during male meiosis.

131 Total Publications
close
Jill Helms

Professor of Surgery (Plastic & Reconstructive Surgery)
Research Interests
Dr. Helms' research interests center around regenerative medicine and craniofacial development.

215 Total Publications
close
Seung K. Kim M.D., Ph.D.

KM Mulberry Professor, Professor of Developmental Biology, of Medicine (Endocrinology) and, by courtesy, of Pediatrics (Endocrinology)
Research Interests
We study the development of pancreatic islet cells using molecular, embryologic and genetic methods in several model systems, including mice, pigs, human pancreas, embryonic stem cells, and Drosophila. Our work suggests that critical factors required for islet development are also needed to maintain essential functions of the mature islet. These approaches have informed efforts to generate replacement islets from renewable sources for diabetes.

89 Total Publications
close
Kyle Loh

Assistant Professor of Developmental Biology (Stem Cell)

54 Total Publications
close
Dr. Michael T. Longaker

Deane P. and Louise Mitchell Professor in the School of Medicine and Professor, by courtesy, of Materials Science and Engineering
Clinical Focus
Plastic Surgery, Plastic Surgery, Pediatric
Research Interests
We have six main areas of current interest: 1) Cranial Suture Developmental Biology, 2) Distraction Osteogenesis, 3) Fibroblast heterogeneity and fibrosis repair, 4) Scarless Fetal Wound Healing, 5) Skeletal Stem Cells, 6) Novel Gene and Stem Cell Therapeutic Approaches.

1144 Total Publications
close
Wan-Jin Lu

Basic Life Research Scientist, Stem Cell Bio Regenerative Med Institute

24 Total Publications
close
Crystal Mackall

Ernest and Amelia Gallo Family Professor and Professor of Pediatrics and of Medicine
Research Interests
Recent clinical studies, by us and others, have demonstrated that genetically engineered T cells can eradicate cancers resistant to all other therapies. We are identifying new targets for these therapeutics, exploring pathways of resistance to current cell therapies and creating next generation platforms to overcome therapeutic resistance. We have discovered novel insights into the biology of human T cell exhaustion and developed approaches to prevent and reverse this phenomenon.

391 Total Publications